576
Views
0
CrossRef citations to date
0
Altmetric
Research Papers

Increasing support for alternatives to incarceration for drug use: is the brain disease model of addiction effective?

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 9-15 | Received 16 Jan 2022, Accepted 13 Jun 2022, Published online: 04 Jul 2022

References

  • Barry CL, McGinty EE, Pescosolido BA, Goldman HH. 2014. Stigma, discrimination, treatment effectiveness, and policy: public views about drug addiction and mental illness. Psychiatr Serv. 65(10):1269–1272.
  • Bell S, Carter A, Mathews R, Gartner C, Lucke J, Hall W. 2014. Views of addiction neuroscientists and clinicians on the clinical impact of a ‘brain disease model of addiction. Neuroethics. 7(1):19–27.
  • Blum TC, Roman PM, Bennett N. 1989. Public images of alcoholism: data from a Georgia survey. J Stud Alcohol. 50(1):5–14.
  • Chopik WJ, O’Brien E, Konrath SH. 2017. Differences in empathic concern and perspective taking across 63 countries. J Cross-Cult Psychol. 48(1):23–38.
  • Des Jarlais DC, McKnight C, Goldblatt C, Purchase D. 2009. Doing harm reduction better: syringe exchange in the United States. Addiction. 104(9):1441–1446.
  • Farrell NR, Lee AA, Deacon BJ. 2015. Biological or psychological? Effects of eating disorder psychoeducation on self-blame and recovery expectations among symptomatic individuals. Behav Res Ther. 74:32–37.
  • Gershkovich M, Deacon BJ, Wheaton MG. 2018. Biomedical causal attributions for obsessive-compulsive disorder: associations with patient perceptions of prognosis and treatment expectancy. J Obs-Compuls Relat Disord. 18:81–85.
  • Giordano VA. 2014. Public acceptance for drug treatment in lieu of incarceration for drug offenders in Florida. J Drug Issues. 44(4):414–429.
  • Hall W, Carter A, Barnett A. 2017. Disease or developmental disorder: competing perspectives on the neuroscience of addiction. Neuroethics. 10(1):103–110.
  • Hall W, Carter A, Forlini C. 2015. The brain disease model of addiction: is it supported by the evidence and has it delivered on its promises? Lancet Psychiatry. 2(1):105–110.
  • Howell AJ, Weikum BA, Dyck HL. 2011. Psychological essentialism and its association with stigmatization. Person Indiv Differ. 50(1):95–100.
  • Kelly JF, Greene MC, Abry A. 2021. A US national randomized study to guide how best to reduce stigma when describing drug-related impairment in practice and policy. Addiction. 116(7):1757–1767.
  • Kloss JD, Lisman SA. 2003. Clinician attributions and disease model perspectives of mentally ill, chemically addicted patients: a preliminary investigation. Subst Use Misuse. 38(14):2097–2107.
  • Kvaale EP, Haslam N, Gottdiener WH. 2013. The ‘side effects’ of medicalization: a meta-analytic review of how biogenetic explanations affect stigma. Clin Psychol Rev. 33(6):782–794.
  • Lebowitz MS, Ahn WK. 2018. Blue genes? Understanding and mitigating negative consequences of personalized information about genetic risk for depression. J Genet Couns. 27(1):204–216.
  • Lebowitz MS, Ahn WK, Nolen-Hoeksema S. 2013. Fixable or fate? Perceptions of the biology of depression. J Consult Clin Psychol. 81(3):518–527.
  • Lebowitz MS, Phil M, Ahn WK. 2015. Emphasizing malleability in the biology of depression: durable effects on perceived agency and prognostic pessimism. Behav Res Ther. 71:125–130.
  • Leshner AI. 1997. Addiction is a brain disease, and it matters. Science. 278(5335):45–44.
  • Lewis M. 2017. Addiction and the brain: development, not disease. Neuroethics. 10(1):7–18.
  • Lewis M. 2018. Brain change in addiction as learning, not disease. N Engl J Med. 379(16):1551–1560.
  • Macdonald S, Erickson P, Allen B. 1999. Judicial attitudes in assault cases involving alcohol or other drugs. J Criminal Justice. 27(3):275–286.
  • McGinty EE, Barry CL, Stone EM, Niederdeppe J, Kennedy-Hendricks A, Linden S, Sherman SG. 2018. Public support for safe consumption sites and syringe services programs to combat the opioid epidemic. Prev Med. 111:73–77.
  • Meurk C, Carter A, Partridge B, Lucke J, Hall W. 2014. How is acceptance of the brain disease model of addiction related to Australians’ attitudes towards addicted individuals and treatments for addiction? BMC Psychiatry. 14(1):373.
  • Meurk C, Hall W, Morphett K, Carter A, Lucke J. 2013. What does “acceptance” mean? Public reflections on the idea that addiction is a brain disease. Biosocieties. 8(4):491–506.
  • Monterosso J, Royzman EB, Schwartz B. 2005. Explaining away responsibility: effects of scientific explanation on perceived culpability. Ethics Behav. 15(2):139–158.
  • Office of the Attorney General. 2017. Department charging and sentencing policy. Memorandum for all federal prosecutors. [accessed 2020 May 1]. https://www.justice.gov/opa/press-release/file/965896
  • Office of the Attorney General. 2018a. Marijuana enforcement. Memorandum for all United States attorneys. [accessed 2020 May 1]. https://www.justice.gov/opa/press-release/file/1022196
  • Office of the Attorney General. 2018b. Guidance regarding use of capital punishment in drug-related prosecutions. Memorandum to United States attorneys. [accessed 2020 May 1]. https://www.justice.gov/file/1045036
  • Pescosolido BA, Martin JK, Long JS, Medina TR, Phelan JC, Link BG. 2010. “A disease like any other”? A decade of change in public reactions to schizophrenia, depression, and alcohol dependence. Am J Psychiatry. 167(11):1321–1330.
  • Peter L-J, Schindler S, Sander C, Schmidt S, Muehlan H, McLaren T, Tomczyk S, Speerforck S, Schomerus G. 2021. Continuum beliefs and mental illness stigma: a systematic review and meta-analysis of correlation and intervention studies. Psychol Med. 51(5):716–726.
  • Pokhrel P, Bennett BL, Regmi S, Idrisov B, Galimov A, Akhmadeeva L, Sussman S. 2018. Individualism-collectivism, social self-control and adolescent substance use and risky sexual behavior. Subst Use Misuse. 53(7):1057–1067.
  • Ricardo MM, Henderson CE. 2021. The effect of the brain disease model of addiction on juror perceptions of culpability. Transl Issues Psychol Sci. 7(2):177–185.
  • Seth P, Scholl L, Rudd RA, Bacon S. 2018. Overdose deaths involving opioids, cocaine, and psychostimulants—United States, 2015–2016. MMWR Morb Mortal Wkly Rep. 67(12):349–358.
  • Sheldon KM, Nichols CP. 2009. Comparing democrats and republicans on intrinsic and extrinsic values. J Appl Soc Psychol. 39(3):589–623.
  • Skitka LJ. 1999. Ideological and attributional boundaries on public compassion: reactions to individuals and communities affected by a natural disaster. Pers Soc Psychol Bull. 25(7):793–808.
  • Skitka LJ, Tetlock PE. 1993. Providing public assistance: cognitive and motivational processes underlying liberal and conservative policy preferences. J Person Soc Psychol. 65(6):1205–1223.
  • Speerforck S, Schomerus G, Matschinger H, Angermeyer MC. 2017. Treatment recommendations for schizophrenia, major depression and alcohol dependence and stigmatizing attitudes of the public: results from a German population survey. Eur Arch Psychiatry Clin Neurosci. 267(4):341–350.
  • Thomas KA, Clifford S. 2017. Validity and mechanical turk: an assessment of exclusion methods and interactive experiments. Comput Hum Behav. 77:184–197.
  • Timberlake JM, Lock ED, Rasinski KA. 2003. How should we wage the war on drugs? Determinants of public preferences for drug control alternatives. Policy Stud J. 31(1):71–88.
  • U.S. Congress. 2018. Substance use–disorder prevention that promotes opioid recovery and treatment for patients and communities act. Washington, DC: U.S. Congress.
  • Volkow ND, Koob G. 2015. Brain disease model of addiction: why is it so controversial? Lancet Psychiatry. 2(8):677–679.
  • Volkow ND, Koob GF, McLellan AT. 2016. Neurobiologic advances from the brain disease model of addiction. N Engl J Med. 374(4):363–371.
  • Volkow ND, Li TK. 2004. Drug addiction: the neurobiology of behaviour gone awry. Nat Rev Neurosci. 5(12):963–970.
  • Wiens TK, Walker LJ. 2015. The chronic disease concept of addiction: helpful or harmful? Addict Res Theory. 23(4):309–321.
  • Zimmermann M, Hmaidan R, Preiser B, Papa A. 2020. The influence of implicit theories of depression on treatment-relevant attitudes. Cognit Ther Res 44:1002–1014.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.